Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71,242Revenue $M23,113Net Margin (%)20.3Z-Score4.6
Enterprise Value $M71,305EPS $4.3Operating Margin %23.2F-Score5
P/E(ttm))17.8Cash Flow Per Share $5.4Pre-tax Margin (%)25.5Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %12.7Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %0.4Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-14.2ROA % (ttm)13.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)1ROE % (ttm)26.6Less Shares Outstanding y-yY
Payout Ratio %55.0Shares Outstanding M1,119ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 63.6414%Add 10.83%57,129,708
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 63.6414%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 63.6414%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 63.6427%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 63.6427%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 63.6427%Add 201.79%141,121
LLYRay Dalio 2013-12-31 Add0.01%$47.65 - $51.34
($50.05)
$ 63.6427%Add 153.37%48,239
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 63.6421%Add 16.91%18,617,000
LLYCharles Brandes 2013-09-30 Add0.23%$49.92 - $54.96
($52.42)
$ 63.6421%Add 16.93%2,409,134
LLYPRIMECAP Management 2013-09-30 Add0.13%$49.92 - $54.96
($52.42)
$ 63.6421%Add 3.98%50,846,997
LLYDavid Dreman 2013-09-30 Buy 0.02%$49.92 - $54.96
($52.42)
$ 63.6421%New holding, 4290 sh.4,290
LLYRay Dalio 2013-09-30 Buy 0.01%$49.92 - $54.96
($52.42)
$ 63.6421%New holding, 19039 sh.19,039
LLYJohn Hussman 2013-09-30 Reduce-1.58%$49.92 - $54.96
($52.42)
$ 63.6421%Reduce -98.57%10,000
LLYJohn Hussman 2013-06-30 Add0.23%$49.06 - $58.33
($54.41)
$ 63.6417%Add 16.64%701,000
LLYPRIMECAP Management 2013-06-30 Add0.14%$49.06 - $58.33
($54.41)
$ 63.6417%Add 4.39%48,900,865
LLYJoel Greenblatt 2013-06-30 Add0.07%$49.06 - $58.33
($54.41)
$ 63.6417%Add 894.98%39,411
LLYGeorge Soros 2013-06-30 Sold Out -0.04%$49.06 - $58.33
($54.41)
$ 63.6417%Sold Out0
LLYJoel Greenblatt 2013-03-31 Buy 0.01%$49.32 - $56.79
($53.91)
$ 63.6418%New holding, 3961 sh.3,961
LLYJohn Hussman 2013-03-31 Reduce-1.03%$49.32 - $56.79
($53.91)
$ 63.6418%Reduce -57.1%601,000
LLYGeorge Soros 2013-03-31 Reduce-0.03%$49.32 - $56.79
($53.91)
$ 63.6418%Reduce -45%55,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY PRIMECAP Management 2014-03-3157,129,7085.13.8+10.83%
LLY David Dreman 2014-03-315,18200.02+8.87%
LLY Vanguard Health Care Fund 2014-03-3122,895,0002.053.8
LLY John Hussman 2014-03-3110,00000.04
LLY Dodge & Cox 2014-03-3135,76000
LLY Charles Brandes 2014-03-312,703,0640.242-0.33%
LLY Mario Gabelli 2014-03-31120,9000.010.04-2.42%
LLY Ray Dalio 2014-03-3131,43900.02-34.83%
LLY Joel Greenblatt 2014-03-319,01600.01-93.61%
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-07-01Sell235,000$62.31.88view
LILLY ENDOWMENT INC10% Owner 2014-06-25Sell245,000$62.681.26view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.623view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.553.12view
LILLY ENDOWMENT INC10% Owner 2014-06-16Sell200,000$58.738.07view
LILLY ENDOWMENT INC10% Owner 2014-06-05Sell190,000$59.536.62view
LILLY ENDOWMENT INC10% Owner 2014-05-21Sell230,000$58.97.76view
LILLY ENDOWMENT INC10% Owner 2014-05-12Sell210,000$59.336.98view
TAI JACKSON PDirector 2014-05-12Buy17,157$59.197.23view
LILLY ENDOWMENT INC10% Owner 2014-05-06Sell190,000$58.797.96view

Press Releases about LLY :

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
Eli Lilly is on the Right Track Jun 25 2014 
John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
Can Pfizer Make Up Its Loss? May 09 2014 
Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
Forest Laboratories' Recovery Mar 18 2014 
AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
Guru Stocks at 52-Week Lows: IBM, T, TLK, LLY, GLD Dec 16 2013 

More From Our Partners
Anthera Acquires Sollpura from Eli Lilly - Analyst Blog Jul 18 2014 - ZACKS

More From Other Websites
Eli Lilly and Immunocore Collaborate to Develop Cancer Drugs Jul 17 2014
[video] Paying for diabetes pandemic Jul 17 2014
Roche Alzheimer's drug fails main goals in mid-stage study Jul 16 2014
Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer... Jul 16 2014
New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of... Jul 16 2014
Eli Lilly joins forces with UK biotech to develop cancer drugs Jul 16 2014
[$$] Eli Lilly, Immunocore Sign $45 million Development Deal Jul 16 2014
Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer... Jul 16 2014
Perrigo retreats after analyst sees limited potential buyers Jul 15 2014
Lilly Offers 'Misleading' Facts in our Patent Dispute, Says Canada Jul 15 2014
Eli Lilly announces results from five datasets from Alzheimer's disease study Jul 15 2014
New Data Shows Cognitive Impairment Precedes and Predicts Subsequent Functional Impairment in... Jul 15 2014
German database study hints diabetes drug cuts Alzheimer's risk Jul 14 2014
New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid... Jul 13 2014
Oncolytics Up on Patient Enrolment Completion Jul 11 2014
[video] The fight against Alzheimer's Jul 11 2014
The fight against Alzheimer's Jul 11 2014
Lilly for Better Health™ expands website's non-product-branded health education resources, focuses... Jul 10 2014
Lilly for Better Health™ expands website's non-product-branded health education resources, focuses... Jul 10 2014
Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement Jul 09 2014
Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement Jul 09 2014
Why Eli Lilly (LLY) Stock Is Down This Afternoon Jul 08 2014
Sanofi sues Eli Lilly over insulin rival to Lantus Jul 08 2014
Sanofi sues Eli Lilly over insulin rival to Lantus Jul 08 2014
CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for... Jun 27 2014
US stock futures little changed Jun 17 2014
Boehringer fixes factory, clearing way for new approval request Jun 03 2014
Cancer meeting a showcase for AstraZeneca drugs prized by Pfizer May 29 2014
Sanofi acquires over-the-counter rights for Cialis May 28 2014
EU approves Eli Lilly-Boehringer diabetes drug May 23 2014
Pfizer seeks early approval for breast cancer drug May 16 2014
Eli Lilly loses Alimta patent case to Actavis May 15 2014
Eli Lilly and Italian firm fined $450 million for poisoning in Brazil May 09 2014
U.S. high court conflicted over Limelight Networks patent fight Apr 30 2014
Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources Apr 30 2014
Bayer offers animal health assets, cash for Merck's OTC unit -sources Apr 29 2014
Exclusive - Allergan eyes new takeover bid for Shire: sources Apr 28 2014
3 more charged in $80M heist in Connecticut Apr 23 2014
Investor pressure pushing drugmaker M&A deals Apr 22 2014
Novartis reshapes business with GSK, Lilly deals Apr 22 2014
Novartis reshapes business with GSK, Lilly dealshe Apr 22 2014
Ahead of the Bell: Shares of drugmaker Lilly slip Apr 22 2014
Eli Lilly to buy Novartis' animal health unit for $5.4 billion Apr 22 2014
Eli Lilly to buy part of Novartis for $5.4 bn Apr 22 2014
Eli Lilly to buy part of Novartis for $5.4 bn Apr 21 2014
US jury hits Takeda, Eli Lilly with $9B penalty Apr 08 2014
US jury hits Takeda, Eli Lilly with $9 bln penalty Apr 08 2014
Drug makers ordered to pay $9bn over diabetes drug claim Apr 08 2014
Drug makers ordered to pay $10bn over diabetes drug claim Apr 08 2014
Lilly to Participate in Barclays Healthcare Conference Mar 05 2014
FDA spurns Lilly, Boehringer diabetes drug, cites factory problems Mar 05 2014
U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin Mar 05 2014
Lilly to Participate in Cowen Healthcare Conference Feb 21 2014
Lilly to Participate in Leerink Swann Global Healthcare Conference Feb 05 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit Jan 31 2014
Sanofi sues Eli Lilly for patent infringement Jan 31 2014
Ex-'King of Biotech' set to serve four-year term for fraud Jan 21 2014
US close: Banks push markets lower, Best Buy tumbles Jan 17 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics Jan 13 2014
Lilly Diabetes/Disney Custom Books for Type 1 Diabetes Families Now Available Online Jan 09 2014
Lilly Oncology On Canvas: Expressions of a Cancer Journey Reaches Important Milestone With 2014... Jan 08 2014
Lilly Announces 2014 Financial Guidance, Reconfirms 2013 Expectations Jan 07 2014
Lilly Sets Dates and Conference Calls for 2014 Financial Guidance and Fourth-Quarter 2013 Financial... Jan 02 2014
Lilly to Present at J.P. Morgan Healthcare Conference Dec 19 2013
Lilly Declares First-Quarter 2014 Dividend Dec 16 2013
Lilly Releases Report on Corporate Responsibility Efforts Dec 05 2013
Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On... Dec 05 2013
Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer... Dec 02 2013
Wall Street up after 5-day slide, Washington eyed Sep 26 2013
Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit Sep 18 2013

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide